Literature DB >> 16575398

Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study.

Paolo Cossu-Rocca1, John N Eble, Shaobo Zhang, Guido Martignoni, Matteo Brunelli, Liang Cheng.   

Abstract

End-stage renal disease is associated with an increased incidence of renal cell neoplasms. Among these, recent studies have identified tumors with unusual histological patterns that do not fit into the categories recognized in the current classification system. These tumors often occur in kidneys with acquired cystic disease and are composed mainly of large eosinophilic cells arranged in solid, cribriform, acinar, or papillary patterns. They also contain deposits of calcium oxalate crystals. We investigated three eosinophilic epithelial tumors arising in kidneys with acquired cystic disease from three patients. Each of the tumors was composed of large eosinophilic cells arranged in solid, acinar, or tubulocystic architecture. Deposits of calcium oxalate crystals were present in each tumor. Hale's colloidal stain showed a positive cytoplasmic reaction in one of the neoplasms. Immunohistochemistry displayed positive results for CD10 (3/3), AE1/AE3 (3/3), alpha-methylacyl-CoA racemase (2/3), CAM5.2 (2/3), and vimentin (1/3). Reactions for epithelial membrane antigen, cytokeratin 7, and high molecular weight cytokeratin (34betaE12) were negative. Fluorescence in situ hybridization analysis showed no losses or gains of chromosomes 1, 2, 6, 10, or 17 in one tumor. There were gains of chromosomes 1, 2, and 6 in two tumors. One of these tumors also showed gains of chromosome 10. Eosinophilic renal cell tumors associated with acquired cystic disease have immunophenotypes and genetic profiles distinct from the renal cell neoplasms recognized in the current classification of renal cell neoplasia, and should be considered as a distinct clinicopathologic entity in the spectrum of renal cell neoplasia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16575398     DOI: 10.1038/modpathol.3800604

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  15 in total

1.  Genomic profiling of renal cell carcinoma in patients with end-stage renal disease.

Authors:  Toru Inoue; Keiko Matsuura; Taichiro Yoshimoto; Lam Tung Nguyen; Yoshiyuki Tsukamoto; Chisato Nakada; Naoki Hijiya; Takahiro Narimatsu; Takeo Nomura; Fuminori Sato; Yoji Nagashima; Kenji Kashima; Shingo Hatakeyama; Chikara Ohyama; Kazuyuki Numakura; Tomonori Habuchi; Masayuki Nakagawa; Masao Seto; Hiromitsu Mimata; Masatsugu Moriyama
Journal:  Cancer Sci       Date:  2012-01-20       Impact factor: 6.716

2.  Mutagenicity evaluation of Anastatica hierochuntica L. aqueous extract in vitro and in vivo.

Authors:  Siti Rosmani Md Zin; Zahurin Mohamed; Mohammed A Alshawsh; Won F Wong; Normadiah M Kassim
Journal:  Exp Biol Med (Maywood)       Date:  2017-12-13

3.  Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y.

Authors:  Naoto Kuroda; Tomoyuki Shiotsu; Ondrej Hes; Michal Michal; Taro Shuin; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2011-01-26       Impact factor: 2.309

4.  Peroxiredoxins, thioredoxin, and Y-box-binding protein-1 are involved in the pathogenesis and progression of dialysis-associated renal cell carcinoma.

Authors:  Fumiyoshi Fushimi; Kenichi Taguchi; Hiroto Izumi; Kimitoshi Kohno; Michihiko Kuwano; Mayumi Ono; Yutaka Nakashima; Tetsuro Takesue; Seiji Naito; Yoshinao Oda
Journal:  Virchows Arch       Date:  2013-08-02       Impact factor: 4.064

Review 5.  Role of cytogenetic biomarkers in management of chronic kidney disease patients: A review.

Authors:  Zeba Khan; Manoj Pandey; Ravindra M Samartha
Journal:  Int J Health Sci (Qassim)       Date:  2016-10

6.  Imaging of acquired cystic disease-associated renal cell carcinoma by contrast-enhanced ultrasonography with perflubutane microbubbles and positron emission tomography-computed tomography.

Authors:  Isao Ishikawa; Kyoko Morita; Satoshi Hayama; Tetsuya Nakazawa; Ichiro Araki; Kotaro Higashi; Katsuhito Miyazawa; Koji Suzuki; Takayuki Nojima
Journal:  Clin Exp Nephrol       Date:  2010-09-09       Impact factor: 2.801

7.  Acquired cystic disease-associated renal cell carcinoma: an immunohistochemical and fluorescence in situ hybridization study.

Authors:  Naoto Kuroda; Motoki Yamashita; Yoshiyuki Kakehi; Ondrej Hes; Michal Michal; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2011-12-17       Impact factor: 2.309

Review 8.  Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas.

Authors:  Qiu Rao; Qiu-Yuan Xia; Liang Cheng; Xiao-Jun Zhou
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

9.  EGFR kinase-dependent and kinase-independent roles in clear cell renal cell carcinoma.

Authors:  Paolo Cossu-Rocca; Maria R Muroni; Francesca Sanges; Giovanni Sotgiu; Anna Asunis; Luciana Tanca; Daniela Onnis; Giovanna Pira; Alessandra Manca; Simone Dore; Maria G Uras; Sara Ena; Maria R De Miglio
Journal:  Am J Cancer Res       Date:  2015-12-15       Impact factor: 6.166

10.  Histological characterisation of small renal masses and incidence of silent renal masses.

Authors:  Sergio Almenar Medina; Ana Calatrava Fons
Journal:  Adv Urol       Date:  2008-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.